Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1966 AL 1980

Clinical Decision Support Using Speech Signal Analysis: Systematic Scoping Review of Neurological Disorders

De Silva U, Madanian S, Olsen S, Templeton JM, Poellabauer C, Schneider SL, Narayanan A, Rubaiat R.

J Med Internet Res. 2025 Jan 13;27:e63004. doi: 10.2196/63004.

Pathophysiological Significance of α-Synuclein in Sympathetic Nerves: In Vivo Observations

Isonaka R, Sullivan P, Goldstein DS.

Neurology. 2025 Feb 11;104(3):e210215. doi: 10.1212/WNL.0000000000210215. Epub 2025 Jan 13.

Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies

Torres-Yaghi Y, Qian J, Cummings H, Shimoda H, Ito S, Batson S, Mitchell S, Pagan F.

Clin Neuropharmacol. 2025 Jan-Feb 01;48(1):7-12. doi: 10.1097/WNF.0000000000000620.

The emerging role of oxygen redox in pathological progression of disorders

Li SY, Gong XY, Ndikuryayo F, Yang WC.

Ageing Res Rev. 2025 Feb;104:102660. doi: 10.1016/j.arr.2025.102660. Epub 2025 Jan 11.

Application trends of hydrogen-generating nanomaterials for the treatment of ROS-related diseases

Li X, Wang X, Chen G, Tian B.

Biomater Sci. 2025 Feb 11;13(4):896-912. doi: 10.1039/d4bm01450b.

Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studies

Rukavina K, Staunton J, Zinzalias P, Krbot Skoric M, Wu K, Bannister K, Rizos A, Ray Chaudhuri K.

PLoS One. 2025 Jan 14;20(1):e0316563. doi: 10.1371/journal.pone.0316563. eCollection 2025.

Reprogramming of updated neurostimulators in chronically implanted patients with Parkinson's disease: A double-blind randomized controlled trial

Boogers A, Justich MB, Montiel M, Alhashyan I, Naghdlou S, Sumarac S, Milosevic L, Lozano AM, Kalia SK, Munhoz RP, Fasano A.

Brain Stimul. 2025 Jan-Feb;18(1):138-140. doi: 10.1016/j.brs.2025.01.006. Epub 2025 Jan 12.

Targeting mitophagy in neurodegenerative diseases

Antico O, Thompson PW, Hertz NT, Muqit MMK, Parton LE.

Nat Rev Drug Discov. 2025 Apr;24(4):276-299. doi: 10.1038/s41573-024-01105-0. Epub 2025 Jan 14.

Gut Microbiota-Based Interventions for Parkinson's Disease: Neuroprotective Mechanisms and Current Perspective

Kumar D, Bishnoi M, Kondepudi KK, Sharma SS.

Probiotics Antimicrob Proteins. 2025 Aug;17(4):2438-2460. doi: 10.1007/s12602-024-10433-x. Epub 2025 Jan 15.

Exploring Dance as a Therapeutic Approach for Parkinson Disease Through the Social Robotics for Active and Healthy Ageing (SI-Robotics): Results From a Technical Feasibility Study

Bevilacqua R, Maranesi E, Benadduci M, Cortellessa G, Umbrico A, Fracasso F, Melone G, Margaritini A, La Forgia A, Di Bitonto P, Potenza A, Fiorini L, La Viola C, Cavallo F, Leone A, Caroppo A, Rescio G, Marzorati M, Cesta A, Pelliccioni G, Riccardi GR, Rossi L.

JMIR Aging. 2025 Jan 14;8:e62930. doi: 10.2196/62930.

Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson's Disease: Exploring Nanoparticle-based Gene Therapies

Jujjavarapu SE, Mishra A.

CNS Neurol Disord Drug Targets. 2025;24(5):325-339. doi: 10.2174/0118715273336139241211071748.

New Multiomic Studies Shed Light on Cellular Diversity and Neuronal Susceptibility in Parkinson's Disease

Liang M, Chu L, Yue Z.

Mov Disord. 2025 Mar;40(3):431-437. doi: 10.1002/mds.30097. Epub 2025 Jan 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias